Cardiotoxicity is a recognised side effect of intravenous 5-fluorouracils. In the two case reports described we demonstrate similar cardiotoxic side effects seen with the use of capecitabine. With the increasing use of oral adjuvant chemotherapeutic agents, capecitabine should be used with caution in those patients with existing coronary artery disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijcard.2007.06.152 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!